| Lisa M Rocchio Phd & Associates | |
|
1524 Atwood Ave Suite 222 Johnston RI 02919-3228 | |
| (401) 751-5880 | |
| (401) 751-5881 |
| Full Name | Lisa M Rocchio Phd & Associates |
|---|---|
| Speciality | Psychologist |
| Location | 1524 Atwood Ave, Johnston, Rhode Island |
| Authorized Official Name and Position | Lisa M Rocchio (PRESIDENT) |
| Authorized Official Contact | 4017515880 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Lisa M Rocchio Phd & Associates 1524 Atwood Ave Suite 222 Johnston RI 02919-3228 Ph: (401) 751-5880 | Lisa M Rocchio Phd & Associates 1524 Atwood Ave Suite 222 Johnston RI 02919-3228 Ph: (401) 751-5880 |
| NPI Number | 1699892687 |
|---|---|
| Provider Enumeration Date | 03/23/2007 |
| Last Update Date | 04/22/2013 |
| Medicare PECOS PAC ID | 6204907066 |
|---|---|
| Medicare Enrollment ID | O20080623000040 |
News Archive
Although prostate cancer may exhibit no symptoms in its early stages, symptoms like severe or unexplained pain, difficulty walking or climbing stairs, difficulty sleeping or loss of bladder control may emerge when the disease advances as a signal to men to take action with their doctors.
Spherix Incorporated, an innovator in biotechnology for diabetes therapy, and a provider of technical and regulatory consulting services to food, supplement, biotechnology and pharmaceutical companies, today announced that it will explore triglycerides as a potential therapeutic opportunity for its D-tagatose therapy, pending a review of data from a Phase 3 clinical trial the Company is conducting on the use of D-tagatose as a treatment for Type 2 diabetes.
Terraboost - creator of the patent pending combination hand sanitizing display/dispenser - announced a new program today to provide complimentary touch-free hand sanitizing displays to businesses worldwide, helping people around the globe mitigate risk related to H1N1 swine flu and other disease-causing bacteria.
In an invited presentation today before the annual meeting of the American Academy of Neurology, Knopp Neurosciences Inc. described further encouraging trends observed in a previously reported Phase 2 study of KNS-760704 (dexpramipexole) in ALS.
› Verified 1 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1699892687 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 103TC1900X | Psychologist - Counseling | PS00631 (Rhode Island) | Primary |
| Provider Name | Martha Dempster |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1053464990 PECOS PAC ID: 0345141859 Enrollment ID: I20040117000066 |
News Archive
Although prostate cancer may exhibit no symptoms in its early stages, symptoms like severe or unexplained pain, difficulty walking or climbing stairs, difficulty sleeping or loss of bladder control may emerge when the disease advances as a signal to men to take action with their doctors.
Spherix Incorporated, an innovator in biotechnology for diabetes therapy, and a provider of technical and regulatory consulting services to food, supplement, biotechnology and pharmaceutical companies, today announced that it will explore triglycerides as a potential therapeutic opportunity for its D-tagatose therapy, pending a review of data from a Phase 3 clinical trial the Company is conducting on the use of D-tagatose as a treatment for Type 2 diabetes.
Terraboost - creator of the patent pending combination hand sanitizing display/dispenser - announced a new program today to provide complimentary touch-free hand sanitizing displays to businesses worldwide, helping people around the globe mitigate risk related to H1N1 swine flu and other disease-causing bacteria.
In an invited presentation today before the annual meeting of the American Academy of Neurology, Knopp Neurosciences Inc. described further encouraging trends observed in a previously reported Phase 2 study of KNS-760704 (dexpramipexole) in ALS.
› Verified 1 days ago
| Provider Name | Lisa M Rocchio |
|---|---|
| Provider Type | Practitioner - Clinical Psychologist |
| Provider Identifiers | NPI Number: 1932241239 PECOS PAC ID: 2668543422 Enrollment ID: I20120113000458 |
News Archive
Although prostate cancer may exhibit no symptoms in its early stages, symptoms like severe or unexplained pain, difficulty walking or climbing stairs, difficulty sleeping or loss of bladder control may emerge when the disease advances as a signal to men to take action with their doctors.
Spherix Incorporated, an innovator in biotechnology for diabetes therapy, and a provider of technical and regulatory consulting services to food, supplement, biotechnology and pharmaceutical companies, today announced that it will explore triglycerides as a potential therapeutic opportunity for its D-tagatose therapy, pending a review of data from a Phase 3 clinical trial the Company is conducting on the use of D-tagatose as a treatment for Type 2 diabetes.
Terraboost - creator of the patent pending combination hand sanitizing display/dispenser - announced a new program today to provide complimentary touch-free hand sanitizing displays to businesses worldwide, helping people around the globe mitigate risk related to H1N1 swine flu and other disease-causing bacteria.
In an invited presentation today before the annual meeting of the American Academy of Neurology, Knopp Neurosciences Inc. described further encouraging trends observed in a previously reported Phase 2 study of KNS-760704 (dexpramipexole) in ALS.
› Verified 1 days ago
| Provider Name | Mary Alice A Mills |
|---|---|
| Provider Type | Practitioner - Clinical Psychologist |
| Provider Identifiers | NPI Number: 1245516731 PECOS PAC ID: 1658533930 Enrollment ID: I20120502000564 |
News Archive
Although prostate cancer may exhibit no symptoms in its early stages, symptoms like severe or unexplained pain, difficulty walking or climbing stairs, difficulty sleeping or loss of bladder control may emerge when the disease advances as a signal to men to take action with their doctors.
Spherix Incorporated, an innovator in biotechnology for diabetes therapy, and a provider of technical and regulatory consulting services to food, supplement, biotechnology and pharmaceutical companies, today announced that it will explore triglycerides as a potential therapeutic opportunity for its D-tagatose therapy, pending a review of data from a Phase 3 clinical trial the Company is conducting on the use of D-tagatose as a treatment for Type 2 diabetes.
Terraboost - creator of the patent pending combination hand sanitizing display/dispenser - announced a new program today to provide complimentary touch-free hand sanitizing displays to businesses worldwide, helping people around the globe mitigate risk related to H1N1 swine flu and other disease-causing bacteria.
In an invited presentation today before the annual meeting of the American Academy of Neurology, Knopp Neurosciences Inc. described further encouraging trends observed in a previously reported Phase 2 study of KNS-760704 (dexpramipexole) in ALS.
› Verified 1 days ago
| Provider Name | Melany C Tromba |
|---|---|
| Provider Type | Practitioner - Clinical Psychologist |
| Provider Identifiers | NPI Number: 1265864045 PECOS PAC ID: 9830323823 Enrollment ID: I20131007000011 |
News Archive
Although prostate cancer may exhibit no symptoms in its early stages, symptoms like severe or unexplained pain, difficulty walking or climbing stairs, difficulty sleeping or loss of bladder control may emerge when the disease advances as a signal to men to take action with their doctors.
Spherix Incorporated, an innovator in biotechnology for diabetes therapy, and a provider of technical and regulatory consulting services to food, supplement, biotechnology and pharmaceutical companies, today announced that it will explore triglycerides as a potential therapeutic opportunity for its D-tagatose therapy, pending a review of data from a Phase 3 clinical trial the Company is conducting on the use of D-tagatose as a treatment for Type 2 diabetes.
Terraboost - creator of the patent pending combination hand sanitizing display/dispenser - announced a new program today to provide complimentary touch-free hand sanitizing displays to businesses worldwide, helping people around the globe mitigate risk related to H1N1 swine flu and other disease-causing bacteria.
In an invited presentation today before the annual meeting of the American Academy of Neurology, Knopp Neurosciences Inc. described further encouraging trends observed in a previously reported Phase 2 study of KNS-760704 (dexpramipexole) in ALS.
› Verified 1 days ago
| Provider Name | Diana Greywolf |
|---|---|
| Provider Type | Practitioner - Clinical Psychologist |
| Provider Identifiers | NPI Number: 1013189216 PECOS PAC ID: 1456493899 Enrollment ID: I20151012000643 |
News Archive
Although prostate cancer may exhibit no symptoms in its early stages, symptoms like severe or unexplained pain, difficulty walking or climbing stairs, difficulty sleeping or loss of bladder control may emerge when the disease advances as a signal to men to take action with their doctors.
Spherix Incorporated, an innovator in biotechnology for diabetes therapy, and a provider of technical and regulatory consulting services to food, supplement, biotechnology and pharmaceutical companies, today announced that it will explore triglycerides as a potential therapeutic opportunity for its D-tagatose therapy, pending a review of data from a Phase 3 clinical trial the Company is conducting on the use of D-tagatose as a treatment for Type 2 diabetes.
Terraboost - creator of the patent pending combination hand sanitizing display/dispenser - announced a new program today to provide complimentary touch-free hand sanitizing displays to businesses worldwide, helping people around the globe mitigate risk related to H1N1 swine flu and other disease-causing bacteria.
In an invited presentation today before the annual meeting of the American Academy of Neurology, Knopp Neurosciences Inc. described further encouraging trends observed in a previously reported Phase 2 study of KNS-760704 (dexpramipexole) in ALS.
› Verified 1 days ago
| Provider Name | Catherine M Doktor |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1578517975 PECOS PAC ID: 3779865860 Enrollment ID: I20170125001805 |
News Archive
Although prostate cancer may exhibit no symptoms in its early stages, symptoms like severe or unexplained pain, difficulty walking or climbing stairs, difficulty sleeping or loss of bladder control may emerge when the disease advances as a signal to men to take action with their doctors.
Spherix Incorporated, an innovator in biotechnology for diabetes therapy, and a provider of technical and regulatory consulting services to food, supplement, biotechnology and pharmaceutical companies, today announced that it will explore triglycerides as a potential therapeutic opportunity for its D-tagatose therapy, pending a review of data from a Phase 3 clinical trial the Company is conducting on the use of D-tagatose as a treatment for Type 2 diabetes.
Terraboost - creator of the patent pending combination hand sanitizing display/dispenser - announced a new program today to provide complimentary touch-free hand sanitizing displays to businesses worldwide, helping people around the globe mitigate risk related to H1N1 swine flu and other disease-causing bacteria.
In an invited presentation today before the annual meeting of the American Academy of Neurology, Knopp Neurosciences Inc. described further encouraging trends observed in a previously reported Phase 2 study of KNS-760704 (dexpramipexole) in ALS.
› Verified 1 days ago
| Provider Name | Amy Beth Basilico |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1851837066 PECOS PAC ID: 4486937299 Enrollment ID: I20170201001609 |
News Archive
Although prostate cancer may exhibit no symptoms in its early stages, symptoms like severe or unexplained pain, difficulty walking or climbing stairs, difficulty sleeping or loss of bladder control may emerge when the disease advances as a signal to men to take action with their doctors.
Spherix Incorporated, an innovator in biotechnology for diabetes therapy, and a provider of technical and regulatory consulting services to food, supplement, biotechnology and pharmaceutical companies, today announced that it will explore triglycerides as a potential therapeutic opportunity for its D-tagatose therapy, pending a review of data from a Phase 3 clinical trial the Company is conducting on the use of D-tagatose as a treatment for Type 2 diabetes.
Terraboost - creator of the patent pending combination hand sanitizing display/dispenser - announced a new program today to provide complimentary touch-free hand sanitizing displays to businesses worldwide, helping people around the globe mitigate risk related to H1N1 swine flu and other disease-causing bacteria.
In an invited presentation today before the annual meeting of the American Academy of Neurology, Knopp Neurosciences Inc. described further encouraging trends observed in a previously reported Phase 2 study of KNS-760704 (dexpramipexole) in ALS.
› Verified 1 days ago
| Provider Name | Irene T Manfredo |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1225243215 PECOS PAC ID: 2466646013 Enrollment ID: I20190502001696 |
News Archive
Although prostate cancer may exhibit no symptoms in its early stages, symptoms like severe or unexplained pain, difficulty walking or climbing stairs, difficulty sleeping or loss of bladder control may emerge when the disease advances as a signal to men to take action with their doctors.
Spherix Incorporated, an innovator in biotechnology for diabetes therapy, and a provider of technical and regulatory consulting services to food, supplement, biotechnology and pharmaceutical companies, today announced that it will explore triglycerides as a potential therapeutic opportunity for its D-tagatose therapy, pending a review of data from a Phase 3 clinical trial the Company is conducting on the use of D-tagatose as a treatment for Type 2 diabetes.
Terraboost - creator of the patent pending combination hand sanitizing display/dispenser - announced a new program today to provide complimentary touch-free hand sanitizing displays to businesses worldwide, helping people around the globe mitigate risk related to H1N1 swine flu and other disease-causing bacteria.
In an invited presentation today before the annual meeting of the American Academy of Neurology, Knopp Neurosciences Inc. described further encouraging trends observed in a previously reported Phase 2 study of KNS-760704 (dexpramipexole) in ALS.
› Verified 1 days ago
News Archive
Although prostate cancer may exhibit no symptoms in its early stages, symptoms like severe or unexplained pain, difficulty walking or climbing stairs, difficulty sleeping or loss of bladder control may emerge when the disease advances as a signal to men to take action with their doctors.
Spherix Incorporated, an innovator in biotechnology for diabetes therapy, and a provider of technical and regulatory consulting services to food, supplement, biotechnology and pharmaceutical companies, today announced that it will explore triglycerides as a potential therapeutic opportunity for its D-tagatose therapy, pending a review of data from a Phase 3 clinical trial the Company is conducting on the use of D-tagatose as a treatment for Type 2 diabetes.
Terraboost - creator of the patent pending combination hand sanitizing display/dispenser - announced a new program today to provide complimentary touch-free hand sanitizing displays to businesses worldwide, helping people around the globe mitigate risk related to H1N1 swine flu and other disease-causing bacteria.
In an invited presentation today before the annual meeting of the American Academy of Neurology, Knopp Neurosciences Inc. described further encouraging trends observed in a previously reported Phase 2 study of KNS-760704 (dexpramipexole) in ALS.
› Verified 1 days ago
The Journey To Hope, Health & Healing, Inc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 985 Plainfield Street, Johnston, RI 02919 Phone: 401-946-0650 Fax: 401-406-3771 | |
Tri-town Substance Abuse Program Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 1126 Hartford Ave, Johnston, RI 02919 Phone: 401-351-2750 Fax: 401-351-6613 | |
Gateway Healthcare, Inc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 1443 Hartford Ave, Johnston, RI 02919 Phone: 401-553-1033 Fax: 401-861-8696 | |
Albert J. Marano, Md, Inc Mental Health Clinic Medicare: Medicare Enrolled Practice Location: 1526 Atwood Ave, Suite 200, Johnston, RI 02919 Phone: 401-272-7660 Fax: 401-421-2730 | |
Delta Consultants West, Inc. Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 1395 Atwood Ave, Suite 213, Johnston, RI 02919 Phone: 401-944-9888 Fax: 401-944-5888 | |
Ocean State Counseling And Wellness Center Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 1395 Atwood Ave, Suite 206, Johnston, RI 02919 Phone: 401-241-3344 Fax: 888-458-2467 | |
Bhg Lvii, Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 985 Plainfield St, Johnston, RI 02919 Phone: 401-946-0650 |